FDA-Drug2026-03-11Class IIPROCESSING DEFECT

Teva Metoprolol Succinate Extended-Release 100 mg tablets recalled for failed dissolution specifications

OTHERNationwide distribution

Stop taking Teva Metoprolol Succinate tablets

Teva Pharmaceuticals is recalling specific batches of Metoprolol Succinate Extended-Release 100 mg tablets because they may not dissolve properly in the body. This means the medication may not work as intended. The recall affects bottles with lot numbers ending in J251 or J252 and expiration dates of 12/2026.

  • Check your Metoprolol bottle for lot number and expiration date against the recall list
  • Contact your pharmacy or doctor if you have an affected batch—do not stop taking your medication without medical guidance
  • Your pharmacist can provide a replacement or alternative blood pressure medication
Hazard

Failed Dissolution Specifications

Sold states
Nationwide
Affected count
7,448 bottles
Manufactured in
400 Interpace Pkwy Bldg A, N/A, Parsippany, NJ, United States
Products
Metoprolol Succinate Extended-Release Tablets, Rx Only, 100 mg, 100 tablets bottles (NDC: 45963-677-11) and 1,000 tablets bottles (NDC: 45963-677-96), Teva Pharmaceuticals, Parsippany, NJ 07054.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0356-2026

More Teva Pharmaceuticals USA, Inc recalls

Don't want to check this manually?

We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Get the Sunday Brief